Does the MMR triple vaccine cause autism?

Miller, 1964, Frequency of complications of measles, 1963. Report on a national inquiry by the Public Health Laboratory Service in collaboration with the Society of Medical Officers of Health, Br Med J, 5401, 75, 10.1136/bmj.2.5401.75 Miller, 1978, Severity of notified measles, Br Med J, 1, 1253, 10.1136/bmj.1.6122.1253 1971 Beard, 1977, The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974, Mayo Clin Proc, 52, 3 Galbraith, 1984, Mumps surveillance in England and Wales 1962-1981, Lancet, 1, 91, 10.1016/S0140-6736(84)90015-1 Atkinson, 1992, Measles surveillance–United States, 1991, MMWR CDC Surveill Summ, 41, 1 van den Hof, 2001, Measles outbreak in a community with very low vaccine coverage, the Netherlands, Emerg Infect Dis, 7, 593, 10.3201/eid0707.017743 van Druten, 1986, Measles, mumps and rubella, Dev Biol Stand, 65, 53 Panagiotopoulos, 1999, Increase in congenital rubella occurrence after immunisation in Greece, BMJ, 319, 1462, 10.1136/bmj.319.7223.1462 World Health Organization. Measles vaccine. Vaccines, Immunization and Biologicals. 2002. Available from: http://www.who.int/vaccine_research/diseases/measles/en/ (accessed 13/5/04). World Health Organization. Mumps vaccine. Vaccines, Immunization and Biologicals. 2004. Available from: http://www.who.int/vaccines-diseases/diseases/mumps_vaccine.shtml (accessed 13/5/04). World Health Organization. Rubella vaccine. Vaccines, Immunization and Biologicals. 2004. Available from: http://www.who.int/vaccines/en/rubella.shtml (accessed 13/5/04) Guinee, 1966, Cooperative measles vaccine field trial. I. Clinical efficacy, Pediatrics, 37, 649, 10.1542/peds.37.4.649 Vaccination against measles: clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Second report to the medical research council by the measles vaccines committee. Br Med J 1968; 2(603):449–452. Pagano, 1969, Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain), Prog Immunobiol Stand, 3, 196 Sugg, 1968, Field evaluation of live virus mumps vaccine, J Pediatr, 72, 461, 10.1016/S0022-3476(68)80334-8 Beasley, 1969, Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27-3 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines, Am J Dis Child, 118, 301, 10.1001/archpedi.1969.02100040303027 Salmon, 1999, Health consequences of religious and philosophical exemptions from immunization laws, JAMA, 282, 47, 10.1001/jama.282.1.47 Gay, 1997, Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule, Commun Dis Rep CDR Rev, 7, R21 Schlegel, 1999, Comparative efficacy of three mumps vaccines during disease outbreak in eastern Switzerland, BMJ, 319, 352, 10.1136/bmj.319.7206.352 Tookey, 2004, Rubella in England, Scotland and Wales, Eurosurveillance Monthly, 9, 21, 10.2807/esm.09.04.00464-en Peltola, 1994, The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program, N Engl J Med, 331, 1397, 10.1056/NEJM199411243312101 Centers for Disease Control. Measles epidemic attributed to inadequate vaccination coverage--Campania, Italy, 2002. MMWR Morb Mortal Wkly Rep 2003;52(43):1044–1047. McBrien, 2003, Measles outbreak in Dublin, 2000, Pediatr Infect Dis J, 22, 580, 10.1097/01.inf.0000073059.57867.36 Siedler A. Measles outbreaks in Germany. Eurosurveillance Weekly http://www.eurosurveillance.org/ew/2002/020321.asp 6(12). 21-3-2002. Schmitt, 2003, Child vaccination policies in Europe, Lancet Infect Dis, 3, 103, 10.1016/S1473-3099(03)00519-X Jansen, 2003, Measles outbreaks in a population with declining vaccine uptake, Science, 301, 804, 10.1126/science.1086726 Health Protection Agency. Completed Primary Courses at Two Years of Age: England and Wales, 1966–1977, England only 1978. 2004. Available from: Available from: http://www.hpa.org.uk/infections/topics_az/vaccination/vac_cover.htm (accessed 13/5/04) Ekbom, 1994, Perinatal measles infection and subsequent Crohn's disease, Lancet, 344, 508, 10.1016/S0140-6736(94)91898-8 Thompson, 1995, Is measles vaccination a risk factor for inflammatory bowel disease? Lancet, 345, 1071 Pardi, 1999, Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease, Inflamm Bowel Dis, 5, 104, 10.1002/ibd.3780050207 Feeney, 1997, A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group, Lancet, 350, 764, 10.1016/S0140-6736(97)03192-9 Morris, 2000, Measles vaccination and inflammatory bowel disease, Am J Gastroenterol, 95, 3507, 10.1111/j.1572-0241.2000.03288.x Wakefield, 1998, Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children, Lancet, 351, 637, 10.1016/S0140-6736(97)11096-0 Chen, 1998, Vaccine adverse events, 351, 611 Peltola, 1998, No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study, Lancet, 351, 1327, 10.1016/S0140-6736(98)24018-9 Taylor, 1999, Autism and measles, mumps, and rubella vaccine, Lancet, 353, 2026, 10.1016/S0140-6736(99)01239-8 Patja, 2000, Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up, Pediatr Infect Dis J, 19, 1127, 10.1097/00006454-200012000-00002 Kaye, 2001, Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners, BMJ, 322, 460, 10.1136/bmj.322.7284.460 Dales, 2001, Time trends in autism and in MMR immunization coverage in California, JAMA, 285, 1183, 10.1001/jama.285.9.1183 Farrington, 2001, MMR and autism, Vaccine, 19, 3632, 10.1016/S0264-410X(01)00097-4 Madsen, 2002, A population-based study of measles, mumps, and rubella vaccination and autism, N Engl J Med, 347, 1477, 10.1056/NEJMoa021134 Institute of Medicine. Immunization Safety Review: Vaccines and Autism. 12-6-2004. Washington DC, National Academy Press. Available from: http://www.nap.edu/books/030909237X/html/ (accessed 12.6.04). Uhlmann, 2002, Potential viral pathogenic mechanism for new variant inflammatory bowel disease, Mol Pathol, 55, 84, 10.1136/mp.55.2.84 Martin, 2002, Detection of measles virus in children with ileo-colonic lymphoid nodular hyperplasia, enterocolitis and developmental disorder, Mol Psychiatry, 7, S47, 10.1038/sj.mp.4001179 Morris, 2002, New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder?, Mol Pathol, 55, 83, 10.1136/mp.55.2.83 Petrovic, 2001, Second dose of measles, mumps, and rubella vaccine, BMJ, 322, 82, 10.1136/bmj.322.7278.82 Smailbegovic, 2003, Why do parents decide against immunization? The effect of health beliefs and health professionals, Child Care Health Dev, 29, 303, 10.1046/j.1365-2214.2003.00347.x Harrabin R, Coote A, Allen J. Health in the News. Risk reporting and media influence. London: King's Fund; 2003. Hargreaves, 2003 Bedford, 2002, MMR vaccine, 73, 100 Murch, 2004, Retraction of an interpretation, Lancet, 363, 750, 10.1016/S0140-6736(04)15715-2